Indication
Reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension (OHT) for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.
Medicine details
- Medicine name:
- netarsudil / latanoprost (Roclanda)
- SMC ID:
- SMC2720
- Pharmaceutical company
- Santen
- BNF chapter
- Eye
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 02 December 2024